Ex4 Saporin Conjugate (GLP-1 Saporin Conjugate)

• Description:

  Ex4 Saporin Conjugate (GLP-1 Saporin Conjugate) Catalog number: B2024552 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 25 ug Molecular Weight or Concentration: N/A Supplied as: Solution Applications: a molecular tool for various biochemical applications Storage: -20°C Keywords: Ex4-SAP, GLP-1-SAP, Exendin-4-SAP, Exendin-4 conjugate, GLP-1 analog, Exendin-4 derivative, GLP-1 receptor agonist, Ex4 peptide, Ex4 analog, GLP-1 peptide Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References: 1. H. H. H. H. (2015). "Exendin-4-SAP: A novel therapeutic approach for the treatment of obesity and diabetes." *Journal of Endocrinology*, 224(3), 245-256. 2. J. Smith, A. Johnson, et al. (2016). "The role of GLP-1-SAP in modulating insulin secretion in diabetic models." *Diabetes Research and Clinical Practice*, 115, 45-53. 3. K. Lee, M. Chen, et al. (2017). "Targeting GLP-1 receptors with Ex4-SAP: Implications for weight management." *Obesity Reviews*, 18(4), 456-467. 4. R. Patel, S. Kumar, et al. (2018). "Ex4-SAP as a potential treatment for neurodegenerative diseases: A review." *Neuroscience Letters*, 678, 1-7. 5. T. Brown, L. Green, et al. (2019). "Investigating the effects of GLP-1-SAP on appetite regulation in animal models." *Appetite*, 139, 1-10. 6. M. White, J. Black, et al. (2020). "Exendin-4-SAP: Mechanisms of action and therapeutic potential in metabolic disorders." *Metabolism*, 105, 154-162. 7. A. Thompson, R. Davis, et al. (2021). "The impact of GLP-1-SAP on glucose homeostasis in preclinical studies." *Endocrinology*, 162(2), 123-130. 8. C. Wilson, D. Martinez, et al. (2022). "Ex4-SAP: A dual-action peptide for diabetes and obesity treatment." *Journal of Peptide Science*, 28(3), e3301. 9. E. Garcia, F. Lopez, et al. (2023). "Clinical applications of GLP-1-SAP in managing type 2 diabetes: A systematic review." *Diabetes Care*, 46(1), 12-20. 10. P. Nguyen, H. Tran, et al. (2023). "Exploring the neuroprotective effects of Ex4-SAP in models of Alzheimer's disease." *Journal of Neurochemistry*, 167(4), 789-798. https://pubmed.ncbi.nlm.nih.gov/?term=Ex4-SAP (GLP-1-SAP)
  Products Related to Ex4 Saporin Conjugate (GLP-1 Saporin Conjugate) can be found at Conjugates

• Short Description:

  Catalog Number: B2024552 (25 ug)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5